Skip to content

The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)

The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations: A Novel Intervention for Children at Risk for Aspiration-Associated Complications (Aim 2)

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07303868
Enrollment
66
Registered
2025-12-26
Start date
2026-10-01
Completion date
2030-08-01
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspiration, Feeding Difficulties, Gastrostomy

Keywords

blenderized, bile acid, gastrostomy, aspiration

Brief summary

Using a four-week randomized, crossover study design, we will assess the impact of 2 weeks of a high bile acid-binding blenderized diet, compared to 2 weeks of a low bile acid-binding blenderized diet, on gastric and salivary bile acid concentrations within individual participants. Four weeks of an amino acid formula will be a comparator group.

Interventions

Low bile acid binding blenderized diet administered for 2 weeks

High bile acid binding blenderized diet administered for 2 weeks

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

Pediatric patients ages 5 to 21 in the randomized arm Inclusion criteria * receive at least 80% of their nutritional needs via gastrostomy * receive blenderized feeds or will start receiving blenderized feeds * have no known allergies to ingredients in blenderized feeds; * receive their bolus feeds within 30 minutes or less * can receive their feeds by syringe push

Exclusion criteria

* have undergone anti-reflux surgery * receive post-pyloric feeds * are allergic to any component of the administered diets * cannot receive their gastrostomy feeds over 30 minutes * require a feeding pump for feed administration (as the H-BBB is too thick for pump administration). Pediatric patients ages 5 to 21 in the observational arm Inclusion * receive at least 80% of their nutritional needs via gastrostomy * are taking an amino acid formula * have not undergone antireflux surgery Exclusion * have undergone anti-reflux surgery * receive post-pyloric feeds * are not receiving an amino acid-based formula.

Design outcomes

Primary

MeasureTime frameDescription
Gastric bile acid concentrationafter 2 weeks on each of 2 diets (cross-over design)differences in total gastric bile acid concentrations at the end of each diet period

Secondary

MeasureTime frameDescription
Gastric bile acid concentrationafter 2 weeks on each of 2 diets (cross-over design)changes in gastric bile acid composition (e.g., change in the proportion of gastric conjugated:unconjugated bile acid) between diet periods
Symptom scoresafter 2 weeks on each of 2 diets (cross-over design)changes in symptoms over the two weeks between diet periods
Salivary and stool bile acid concentrationsafter 2 weeks on each of 2 diets (cross-over design)changes in the total salivary and stool BA concentrations between diet periods;
Serum complement 4 (C4)after 2 weeks on each of 2 diets (cross-over design)changes in serum C4 between diet periods
gastric, salivary, and stool bile acidafter 2 weeks on each of 2 diets (cross-over design)changes in gastric, salivary, and stool bile acid over time between the high bile binding blend, low bile binding blend and amino acid-based formula groups.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026